Hillsdale Investment Management Inc. Bristol Myers Squibb CO Transaction History

Hillsdale Investment Management Inc.

  • $1.21 Billion
  • Q3 2024

A detailed history of Hillsdale Investment Management Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Hillsdale Investment Management Inc. holds 400 shares of BMY stock, worth $23,708. This represents 0.0% of its overall portfolio holdings.

Number of Shares
400
Holding current value
$23,708
% of portfolio
0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$39.66 - $51.75 $15,863 - $20,700
400 New
400 $20,000
Q1 2024

May 10, 2024
SELL
$47.98 - $54.4 $39,823 - $45,152
-830 Reduced 37.32%
1,394 $75,000
Q3 2023

Nov 09, 2023
SELL
$57.89 - $64.73 $383,810 - $429,159
-6,630 Reduced 74.88%
2,224 $129,000
Q1 2023

May 10, 2023
SELL
$65.71 - $74.53 $6,570 - $7,453
-100 Reduced 1.12%
8,854 $613,000
Q4 2022

Feb 13, 2023
SELL
$68.48 - $81.09 $69,849 - $82,711
-1,020 Reduced 10.23%
8,954 $644,000
Q3 2022

Nov 10, 2022
BUY
$0.13 - $76.84 $25 - $15,060
196 Added 2.0%
9,974 $709,000
Q2 2022

Aug 12, 2022
SELL
$72.62 - $79.98 $29,048 - $31,992
-400 Reduced 3.93%
9,778 $753,000
Q1 2022

Apr 28, 2022
BUY
$61.48 - $73.72 $12,296 - $14,744
200 Added 2.0%
10,178 $744,000
Q3 2021

Oct 21, 2021
BUY
$59.17 - $69.31 $532,530 - $623,790
9,000 Added 920.25%
9,978 $590,000
Q2 2021

Jul 29, 2021
SELL
$61.91 - $67.42 $50,270 - $54,745
-812 Reduced 45.36%
978 $65,000
Q1 2021

Apr 22, 2021
BUY
$59.34 - $66.74 $7,714 - $8,676
130 Added 7.83%
1,790 $113,000
Q4 2020

Feb 09, 2021
SELL
$57.74 - $65.43 $432,472 - $490,070
-7,490 Reduced 81.86%
1,660 $103,000
Q3 2020

Nov 13, 2020
SELL
$57.43 - $63.64 $18,377 - $20,364
-320 Reduced 3.38%
9,150 $552,000
Q2 2020

Aug 11, 2020
SELL
$54.82 - $64.09 $5,482 - $6,409
-100 Reduced 1.04%
9,470 $557,000
Q1 2020

May 12, 2020
BUY
$46.4 - $67.43 $379,088 - $550,903
8,170 Added 583.57%
9,570 $533,000
Q3 2019

Nov 13, 2019
SELL
$42.77 - $50.71 $28,228 - $33,468
-660 Reduced 32.04%
1,400 $71,000
Q2 2019

Aug 02, 2019
SELL
$44.62 - $49.34 $394,887 - $436,659
-8,850 Reduced 81.12%
2,060 $93,000
Q1 2019

May 13, 2019
BUY
$45.12 - $53.8 $153,859 - $183,458
3,410 Added 45.47%
10,910 $521,000
Q2 2018

Aug 13, 2018
BUY
$50.53 - $62.98 $378,975 - $472,350
7,500 New
7,500 $415,000
Q1 2018

May 14, 2018
SELL
$59.92 - $68.98 $349,932 - $402,843
-5,840 Closed
0 $0
Q2 2017

Aug 14, 2017
BUY
N/A
5,840
5,840 $326,000

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $126B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Hillsdale Investment Management Inc. Portfolio

Follow Hillsdale Investment Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hillsdale Investment Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email